Erythropoietin Stimulates Tumor Growth via EphB4.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Cell

• Publication date

  2015-11-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccell.2015.09.008PMID 26481148PMCID PMC4643364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue-based map of the human proteome

  2015cited by this paper
• Erythropoietin Stimulates Tumor Growth via EphB4

  2015cited by this paper
• Hypoxia Mediated Downregulation of miRNA Biogenesis Promotes Tumor Progression

  2014cited by this paper
• 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity

  2014cited by this paper
• Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

  2014cited by this paper
• The Receptor That Tames the Innate Immune Response

  2012cited by this paper
• Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

  2012cited by this paper
• Erythropoietin, erythropoiesis and beyond.

  2011cited by this paper
• Molecular Interaction Studies Using Microscale Thermophoresis

  2011cited by this paper
• Erythropoietin Receptor Contributes to Melanoma Cell Survival in vivo

  2011influential reference
• The Role of Erythropoietin and Erythropoiesis-Stimulating Agents in Tumor Progression

  2011cited by this paper
• Nonerythropoietic Properties of Erythropoietin

  2011cited by this paper
• Erythropoietin for oncology supportive care.

  2011cited by this paper
• Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma.

  2011influential reference
• Role of erythropoeitin in prevention of chemotherapy-induced peripheral neuropathy.

  2010cited by this paper
• SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer.

  2010cited by this paper
• Regulation of tumor angiogenesis by EZH2.

  2010cited by this paper
• Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor

  2010cited by this paper
• Hematology: ESAs to treat anemia—balancing the risks and benefits

  2009cited by this paper
• Use of erythropoietin-stimulating agents in breast cancer patients: a risk review.

  2009influential reference
• Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.

  2009cited by this paper
• Erythropoietin in cancer patients.

  2009cited by this paper
• Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.

  2009cited by this paper
• Erythropoietin in cancer: an update.

  2008influential reference
• Erythropoietin: physiology and molecular mechanisms

  2008cited by this paper
• Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.

  2008cited by this paper
• Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

  2008cited by this paper
• Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.

  2008cited by this paper
• HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

  2008cited by this paper
• Glucagon receptors

  2008cited by this paper
• Dicer, Drosha, and outcomes in patients with ovarian cancer.

  2008cited by this paper
• Role of erythropoietin in the brain.

  2007cited by this paper
• Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells

  2007cited by this paper
• Population Pharmacokinetics Meta-Analysis of Recombinant Human Erythropoietin in Healthy Subjects

  2007cited by this paper
• Does Erythropoietin Have a Dark Side? Epo Signaling and Cancer Cells

  2007cited by this paper
• Structural and Biophysical Characterization of the EphB4·EphrinB2 Protein-Protein Interaction and Receptor Specificity*

  2006cited by this paper
• EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.

  2006cited by this paper
• Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

  2006cited by this paper
• Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.

  2006cited by this paper
• Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells

  2005cited by this paper
• Erythropoietin Improves Functional and Histological Outcome in Neonatal Stroke

  2005cited by this paper
• Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.

  2005cited by this paper
• Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic

  2004cited by this paper
• The CD8 T Cell Coreceptor Exhibits Disproportionate Biological Activity at Extremely Low Binding Affinities*

  2003cited by this paper
• Efficiency of signalling through cytokine receptors depends critically on receptor orientation

  1998cited by this paper
• Interleukin-3 (IL-3) Inhibits Erythropoietin-induced Differentiation in Ba/F3 Cells via the IL-3 Receptor α Subunit*

  1996cited by this paper
• Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers.

  1990cited by this paper
• Identification of distinct receptor complexes that account for high-and low-affinity glucagon binding to hepatic plasma membranes.

  1985cited by this paper
• Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

  1985cited by this paper
• THE AMERICAN FEDERATION FOR CLINICAL RESEARCH.

  1942cited by this paper

• Patient Blood Management in Cancer Surgery.

  2026cites this paper
• Tetravalent antibodies are more potent and efficacious erythropoiesis‐stimulating agents than erythropoietin in vivo

  2026cites this paper
• Erythropoietin promotes cell proliferation in Neuro-2A mouse neuroblastoma cells

  2025cites this paper
• An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo

  2025cites this paper
• Anaemia in Cancer Patients: Advances and Challenges in the Era of Precision Oncology.

  2025cites this paper
• Forebrain-specific loss of erythropoietin provokes compensatory upregulation of different EPO receptors

  2025cites this paper
• Effect of recombinant human erythropoietin on postoperative anemia in children and adolescents undergoing osteosarcoma and potential influencing factors: a single-center retrospective study

  2025cites this paper
• Pre-treatment anemia in head and neck cancer: risk factors, subtypes, and survival outcomes

  2025cites this paper
• Mechanisms and Management of Albumin-Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer

  2025cites this paper
• Mechanisms of Postischemic Stroke Angiogenesis: A Multifaceted Approach

  2024cites this paper
• Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches

  2024cites this paper
• Lipoprotein metabolism mediates hematopoietic stem cell responses under acute anemic conditions

  2024cites this paper
• Will Prolyl Hydroxylase Inhibitors Supplant Erythropoiesis-Stimulating Agents and IV Iron in the Treatment of Chemotherapy-Induced Anemia?

  2024cites this paper
• Erythroid Cells as Full Participants in the Tumor Microenvironment

  2023cites this paper
• Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression

  2023cites this paper
• Eph receptors and ephrins in cancer progression

  2023cites this paper
• Heterogeneity in leukemia cells that escape drug-induced senescence-like state

  2023influential citation
• Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-JAK2-STAT3 axis.

  2023cites this paper
• Tumor-associated myeloid cells in cancer immunotherapy

  2023cites this paper
• Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy

  2023cites this paper
• Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment

  2023cites this paper
• Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives

  2023cites this paper
• An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors

  2023cites this paper
• Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms

  2023cites this paper
• Erythropoietin Interacts with Specific S100 Proteins

  2022cites this paper
• Erythropoietin induces odontoblastic differentiation of human-derived pulp stem cells via EphB4-Mediated MAPK signaling pathway.

  2022cites this paper
• The COVID-19 explorer—An integrated, whole patient knowledge model of COVID-19 disease

  2022cites this paper
• The Latest Evidence of Erythropoietin in the Treatment of Glaucoma

  2022cites this paper
• Targeting Stress Erythropoiesis Pathways in Cancer

  2022cites this paper
• Carbon Dots as a Potential Therapeutic Agent for the Treatment of Cancer‐Related Anemia

  2022cites this paper
• The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review

  2022cites this paper
• Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update

  2022cites this paper
• Loading of erythropoietin on biphasic calcium phosphate bioceramics promotes osteogenesis and angiogenesis by regulating EphB4/EphrinB2 molecules

  2022cites this paper
• Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection

  2021cites this paper
• Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis—Mechanistic Insights into Anemia of Inflammation and Its Treatment

  2021cites this paper
• Chronic Dialysis Patients Are Depleted of Creatine: Review and Rationale for Intradialytic Creatine Supplementation

  2021cites this paper
• The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization

  2021cites this paper
• Erythropoietin and derivatives: Potential beneficial effects on the brain

  2021cites this paper
• STAT5 as a Key Protein of Erythropoietin Signalization

  2021cites this paper
• Cytoprotective effects of erythropoietin: What about the lung?

  2021cites this paper
• Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.

  2021cites this paper
• Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell Carcinomas

  2020cites this paper
• Use of preoperative erythropoietin therapy to facilitate autologous blood donation in orthopedic surgery

  2020cites this paper
• The Many Facets of Erythropoietin Physiologic and Metabolic Response

  2020cites this paper
• Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions

  2020cites this paper
• Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib.

  2020cites this paper
• ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis

  2020cites this paper
• Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.

  2020cites this paper
• Dietary luteolin protects against renal anemia in mice

  2020cites this paper
• The Ephrin receptor A2 and Roundabout Guidance Receptor 1 heterodimer: A potential theranostic for squamous cell carcinomas

  2020cites this paper
• Erythropoietin directly affects single hematopoietic stem cell differentiation after transplantation

  2020cites this paper
• Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer

  2020cites this paper
• Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.

  2020cites this paper
• How I treat Cancer Anemia.

  2020cites this paper
• Erythropoietin regulation of red blood cell production: from bench to bedside and back

  2020cites this paper
• How I treat cancer-associated anemia

  2020cites this paper
• Angiotensin-converting enzyme inhibitors have adverse effects in anti-angiogenesis therapy for hepatocellular carcinoma.

  2020cites this paper
• The rationality and mechanism of ACEIs for the treatment of proteinuria caused by antiangiogenic drugs in hepatocellular carcinoma

  2020cites this paper
• Bradykinin promotes proliferation, migration, and invasion of cervical cancer cells through STAT3 signaling pathways

  2019cites this paper
• Prevention and Treatment for Chemotherapy-Induced Peripheral 
Neuropathy: Therapies Based on CIPN Mechanisms

  2019cites this paper
• Erythropoiesis, EPO, macrophages, and bone.

  2019cites this paper
• The Orphan Cytokine Receptor CRLF3 Emerged With the Origin of the Nervous System and Is a Neuroprotective Erythropoietin Receptor in Locusts

  2019cites this paper
• Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity

  2019cites this paper
• Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients

  2019cites this paper
• Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity

  2019cites this paper
• Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.

  2019cites this paper
• EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells

  2019cites this paper
• Molecular targets for improving arteriovenous fistula maturation and patency

  2019cites this paper
• Identification of potential prognostic TF‐associated lncRNAs for predicting survival in ovarian cancer

  2018cites this paper
• 99m Tc-labeled rHuEpo for imaging of the erythropoietin receptor in tumors.

  2018cites this paper
• Alternative Erythropoietin Receptors in the Nervous System

  2018influential citation
• [Erythropoietin accelerates the proliferation of glioma cells via activating Akt pathway].

  2018cites this paper
• Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements

  2018cites this paper
• Peptide Derivatives of Erythropoietin in the Treatment of Neuroinflammation and Neurodegeneration.

  2018cites this paper
• Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer.

  2018cites this paper
• First‐in‐man–proof of concept study with molidustat: a novel selective oral HIF‐prolyl hydroxylase inhibitor for the treatment of renal anaemia

  2018cites this paper
• Inhibition of EphB4–Ephrin-B2 Signaling Enhances Response to Cetuximab–Radiation Therapy in Head and Neck Cancers

  2018influential citation
• Erythropoietin Promotes Glioblastoma via miR-451 Suppression.

  2017cites this paper
• Study of angiogenic signaling pathways in hemangioblastoma

  2017influential citation
• Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer

  2017cites this paper
• Erythropoietin-Mediated Neuroprotection in Insects Suggests a Prevertebrate Evolution of Erythropoietin-Like Signaling.

  2017cites this paper
• Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target

  2017cites this paper
• Intradialytic creatine supplementation: A scientific rationale for improving the health and quality of life of dialysis patients.

  2017cites this paper
• Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.

  2017cites this paper
• Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology

  2017cites this paper
• Long Noncoding RNA in Cancer: Wiring Signaling Circuitry.

  2017cites this paper
• Efficacy and safety of erythrocytapheresis and low‐dose erythropoietin for treatment of hemochromatosis

  2017cites this paper
• Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.

  2017cites this paper
• Clinical Significance of Homologous Recombination Deficiency Score Testing in Endometrial Cancer

  2016cites this paper
• Erythropoietin Pathway: A Potential Target for the Treatment of Depression

  2016cites this paper
• AMPKα1 deletion in fibroblasts promotes tumorigenesis in athymic nude mice by p52-mediated elevation of erythropoietin and CDK2

  2016cites this paper
• Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas

  2016cites this paper
• Bayesian semiparametric analysis of short- and long-term hazard ratios with covariates

  2014cites this paper